SCHEMBL19953115

SCHEMBL19953115

COc1ccc(F)c(/C=N/c2ccc(Cl)cc2)c1F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.48
CYP1A2 P05177 3/20 0.48
GAA P10253 3/20 0.48
CYP2C19 P33261 2/20 0.48
ALDH1A1 P00352 2/20 0.48
CYP2C9 P11712 2/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
KMT2A Q03164 3/20 0.43
RECQL P46063 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PTGS2 P35354 5/20 0.38
POLB P06746 1/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA9 Q16790 1/20 0.37
PTGS1 P23219 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19953197 0.82 CYP1A2 (0.46) MAPTCYP1A2GAACYP2C19ALDH1A1
SCHEMBL19953073 0.80 CYP1A2 (0.42) MAPTCYP1A2GAACYP2C19ALDH1A1
SCHEMBL19952993 0.79 CYP1A2 (0.44) MAPTCYP1A2GAACYP2C19ALDH1A1
SCHEMBL19953070 0.79 CYP1A2 (0.44) MAPTCYP1A2GAACYP2C19ALDH1A1
SCHEMBL19976855 0.77 TUBB1 (0.39) MAPTCYP1A2ALDH1A1HPGDPTGS2
SCHEMBL19967280 0.76 CYP1A2 (0.42) MAPTCYP1A2GAACYP2C19ALDH1A1
SCHEMBL19953208 0.76 CA2 (0.43) MAPTCYP1A2GAACYP2C19ALDH1A1
SCHEMBL1163846 0.75 CYP1A2 (0.46) MAPTCYP1A2GAACYP2C19ALDH1A1
SCHEMBL19953160 0.75 CYP1A2 (0.46) MAPTCYP1A2GAACYP2C19ALDH1A1
SCHEMBL1163845 0.75 CYP1A2 (0.46) MAPTCYP1A2GAACYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018048969-A1 MULTI-TARGETED HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2018-03-15 WO disclosed